C. J. Currie

2.0k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

C. J. Currie is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, C. J. Currie has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in C. J. Currie's work include Chronic Disease Management Strategies (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). C. J. Currie is often cited by papers focused on Chronic Disease Management Strategies (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). C. J. Currie collaborates with scholars based in United Kingdom, United States and Canada. C. J. Currie's co-authors include C Poole, E.A.M. Gale, John R. Peters, P. K. Hopkinson, A Bagust, Sara Jenkins‐Jones, Sarah E. Holden, Chris D. Poole, CL Morgan and Jeffrey Johnson and has published in prestigious journals such as BMJ, Journal of Hepatology and Diabetologia.

In The Last Decade

C. J. Currie

15 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

2009 877 citations C. J. Currie, C Poole et al. Diabetologia profile →

Peers

C. J. Currie

MB

EDM

ONCOL

SURGE

CR

C Poole United Kingdom

Maria Düring Denmark

Rachel Derr United States

Adalberto Miranda‐Filho France

Manjinder S. Sandhu United Kingdom

Kimberly S. Peairs United States

Fen Liu China

Lingbin Du China

Olufemi J. Ogunbiyi Nigeria

Dingli Song China

C Poole United Kingdom

C. J. Currie

776 ×0.9

MB

479 ×0.7

EDM

388 ×1.0

ONCOL

225 ×0.9

SURGE

203 ×1.0

CR

Citations per year, relative to C. J. Currie C. J. Currie (= 1×) peers C Poole

Countries citing papers authored by C. J. Currie

Since Specialization

Citations

This map shows the geographic impact of C. J. Currie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. J. Currie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. J. Currie more than expected).

Fields of papers citing papers by C. J. Currie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. J. Currie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. J. Currie. The network helps show where C. J. Currie may publish in the future.

Co-authorship network of co-authors of C. J. Currie

This figure shows the co-authorship network connecting the top 25 collaborators of C. J. Currie. A scholar is included among the top collaborators of C. J. Currie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. J. Currie. C. J. Currie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Currie, C. J., Ellen Berni, Sara Jenkins‐Jones, et al.. (2014). Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. BMJ. 349(sep23 3). g5493–g5493. 87 indexed citations

2.

Orr, James, Christopher Ll. Morgan, Sara Jenkins‐Jones, et al.. (2014). P478 RESOURCE USE ASSOCIATED WITH HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER DISEASE. Journal of Hepatology. 60(1). S228–S229. 7 indexed citations

3.

Holden, Sarah E. & C. J. Currie. (2014). Mortality risk with sulphonylureas compared to metformin. Diabetes Obesity and Metabolism. 16(10). 885–890. 20 indexed citations

4.

Morgan, Christopher Ll., et al.. (2014). P452 MORTALITY ASSOCIATED WITH HEPATIC ENCEPHALOPATHY IN PATIENTS WITH SEVERE LIVER DISEASE. Journal of Hepatology. 60(1). S219–S219. 1 indexed citations

5.

Holden, Sarah E., Juliana Setyawan, David Coghill, P. Hodgkins, & C. J. Currie. (2013). 1041 – The Incidence, Resource Utilization And Financial Costs Of Treating Children With Attention Deficit/hyperactivity Disorder (adhd) In The United Kingdom (uk). European Psychiatry. 28(S1). 1 indexed citations

6.

Holden, Sarah E., Anthony Barnett, John R. Peters, et al.. (2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obesity and Metabolism. 15(9). 844–852. 98 indexed citations

7.

Poole, Chris D., et al.. (2012). PMS19 Impact of Disease Severity on the Total, Health-Related, Financial Costs of Treatment of People with Rheumatoid Arthritis in the United Kingdom. Value in Health. 15(4). A36–A37. 1 indexed citations

8.

Currie, C. J. & Jeffrey Johnson. (2011). The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Diabetes Obesity and Metabolism. 14(1). 1–4. 41 indexed citations

9.

Poole, C, M. Lebmeier, Roberta Ara, Rachid Rafia, & C. J. Currie. (2010). Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK. Lara D. Veeken. 49(10). 1949–1956. 36 indexed citations

10.

Morgan, CL, John R. Peters, & C. J. Currie. (2010). The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK*. Diabetic Medicine. 27(6). 673–678. 22 indexed citations

11.

Currie, C. J., C Poole, & E.A.M. Gale. (2009). The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 52(9). 1766–1777. 877 indexed citations breakdown →

12.

Currie, C. J., Chris D. Poole, & E.A.M. Gale. (2009). 4 The influence of glucose-lowering therapies on cancer risk. 1 indexed citations

13.

Currie, C. J., et al.. (2007). The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabetic Medicine. 24(2). 187–194. 50 indexed citations

14.

Bagust, A, et al.. (2002). The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. Diabetic Medicine. 19(s4). 1–5. 114 indexed citations

15.

Currie, C. J., et al.. (1997). NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabetic Medicine. 14(8). 686–692. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact